Abstract
The difficulty of treatment of malignant tumors reflects the complexity of life sciences. The histo- and cytopathological changes from the previous histopathological diagnosis and the macroscopic imaging changes from a variety of imaging diagnosis have provided irreplaceable information for the diagnosis and prognosis evaluation of tumors. In recent years, with the development of molecular biology, the solutions for the difficult problems of oncology have been found out. The essence of tumor metastasis refers to the “invasive property” of cancer cells, which is the result of a series of genetic changes, fundamentally. Under what conditions the gene mutated to form the benign nevus, and under what conditions the gene mutated to form the invasive melanoma? From the view of dialectics, is there a possibility of mutual transformation? The ideal situation is to solve the macroscopic problems such as metastasis of malignant tumor through microscopic approaches, and then come back to the macroscopic level to achieve the prediction of tumor metastasis and the development of new drugs. Under the guidance of integrative medicine, we are looking forward to a promising future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology. 2002;109(12):2197–206.
Diener-West M, Reynolds SM, Agugliaro DJ, et al. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22(12):2438–44.
Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol. 1978;62(6):420–5.
Damato B, Eleuteri A, Taktak AF, et al. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30(5):285–95.
Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347(9010):1222–5.
Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410–3.
Onken MD, Worley LA, Ehlers JP, et al. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205–9.
Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010;363:2191–9.
Xu X, Wei WB, Li B, et al. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. PLoS One. 2014;9(10):e109699.
Infante JR, Papadopoulos KP, Bendell JC, et al. A phase 1b study of trametinib, an oral mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours. Eur J Cancer. 2013;49:2077–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Xu, X., Zhang, X. (2020). Integrative Analysis of Uveal Melanoma. In: Wang, N. (eds) Integrative Ophthalmology. Advances in Visual Science and Eye Diseases, vol 3. Springer, Singapore. https://doi.org/10.1007/978-981-13-7896-6_18
Download citation
DOI: https://doi.org/10.1007/978-981-13-7896-6_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7895-9
Online ISBN: 978-981-13-7896-6
eBook Packages: MedicineMedicine (R0)